Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > My "intrinsic unlocked book value" is +$20

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Mar 26, 2024 2:08pm

137 Views

Post# 35953533

My "intrinsic unlocked book value" is +$20

TD is NOT putting any value on their drug pipeline at all. Where as having watched Pfizer and Astrazeneca acquisitions, my book value represents 25% home runs of their drug pipeline and while I write this, TD securities is very active on the 'buy side'.

<< Previous

Bullboard Posts

Next >>

Canadian government to fund Electric Royalties portfolio property